The Sickle Cell Disease Health Passport was developed with the aim of empowering patients to have ownership of their medical records. The passport contains patients’ socio-demographic information as well as records of hospital visits.
Members of the SPARCO Nigeria Site were part of a team of experts who met to include SCD in the World Health Organization Package of Essential Non-Communicable Diseases Interventions for Primary Health Care (WHO PEN).
The first SADaCC and SPARCO Consortium meeting was held in Dar es Salaam, Tanzania and was attended by 30 participants with one participant joining remotely from the US via Skype (whenever the network allowed). The main aim of this 1st SADaCC & SPARCO consortium meeting was optimization of SPARCO and SADaCC implementation plans with the following objectives: a) To review and adjust the project’s milestones and work-plans based on feedback from representatives from all collaborating sites; b) To collect baseline data and conduct a formative assessment of the current status of each site and use this data to adapt the project plan accordingly and for future evaluations; c) To initiate sustainability plans.
HemoTypeSC™, is a novel rapid point of care test that uses a lateral flow immunoassay method to detect the presence of HbA, HbS, and HbC with monoclonal antibodies that have very low limits of detection for HbA, HbS, and HbC antigens.
In the same way that you protect your possessions, you also need to secure your cyber environment from potential threats. Find out more about how to protect yourself from these threats, and the security measures in place at UCT.
This is the inaugural issue of Sickle In Africa, a bi-annual Newsletter for the Sickle Africa Data Coordinating Center (SADaCC), Sickle Pan African Research Consortium (SPARCO) and the Sickle Pan-African Network (SPAN).